Cancer Cause and Prevention Research in South Dakota
Cancer Cause and Prevention Research (93.393) awarded $3.1 million to recipients in South Dakota in 3 grants from fiscal 2021 to 2025, less than 0.1% of the program's national total. The University of South Dakota received the most, $1.2 million.
- Awarded in South Dakota$3.1 million
- Awards3
- Share of the programless than 0.1%
- Rank among states43rd of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $377,438 |
| FY 2022 | 2 | $577,438 |
| FY 2023 | 2 | $569,889 |
| FY 2024 | 2 | $500,374 |
| FY 2025 | 2 | $1.1 million |
Recipients in South Dakota
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The University of South Dakota | Colleges and universities | 1 | $1.2 million |
| Sanford Research | Nonprofits | 1 | $1.1 million |
| Black Hills Center for American Indian Health | Nonprofits | 1 | $800,000 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to South Dakota?
$3.1 million from fiscal 2021 to 2025, across 3 awards. South Dakota ranks 43rd of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in South Dakota?
The largest recipient is The University of South Dakota, with $1.2 million in 1 award. Next are Sanford Research and Black Hills Center for American Indian Health.
Can organizations in South Dakota apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in South Dakota
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Impact Aid
- National School Lunch Program
- Child Care and Development Block Grant
- Airport Improvement Program, Infrastructure Investment and Jobs Act Programs, and COVID-19 Airports Programs
- Head Start
- Title I Grants to Local Educational Agencies
- Indian Housing Block Grants